In a previous randomized trial, we demonstrated that propranolol prevented recurrent gastrointestinal bleeding in patients with cirrhosis. We have undertaken the present study in a new group of patients to ascertain the factors associated with rebleeding. Among 232 patients with cirrhosis admitted f
Propranolol for Prevention of Recurrent Gastrointestinal Bleeding in Patients with Cirrhosis
โ Scribed by Lebrec, Didier; Poynard, Thierry; Hillon, Patrick; Benhamou, Jean-Pierre
- Book ID
- 118000794
- Publisher
- Massachusetts Medical Society
- Year
- 1981
- Tongue
- English
- Weight
- 631 KB
- Volume
- 305
- Category
- Article
- ISSN
- 0096-6762
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
We have previously reported the results of a controlled trial showing that continuous oral administration of propranolol reduced the risk of recurrent gastrointestinal bleeding in patients with cirrhosis; only part of our patients had been followed for 1 year. This controlled trial was continued for
To assess the efficacy of &blockers in preventing rebleeding in selected cirrhotic patients and to compare the tolerance, safety and patient compliance of a selective and a nonselective @-blocker, 9 4 patients were randomly assigned to propranolol (32 patients), atenolol (32 patients) or placebo (30